About this medicine
- Approved name
- Strenzen 500/125-mg/g powder
- International non-proprietary name (INN) or common name
- amoxicillin
- clavulanic acid
About this procedure
- Current status
- European Commission final decision
- Reference number
- EMEA/V/A/085
- Type
- Article 33
Mutual-recognition and decentralised referral: initiated because of disagreement between Member States within the framework of the mutual-recognition or decentralised procedure.
Key dates and outcomes
- Opinion date
- 10/04/2013
- EC decision date
- 12/08/2013